支架合并房颤抗栓:可考虑7个建议( 三 )
参考文献
[2]Angiolillo DJ, Goodman SG, Bhatt DL, et al. Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update[J]. Circ Cardiovasc Interv. 2016 ,9(11):e004395.
[3]Lip GYH, Collet JP, Haude M, et al. ESC Scientific Document Group. 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA) [J]. Europace, 2019,21(2):192-193.
[4]Angiolillo DJ, Goodman SG, Bhatt DL, et al. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update[J]. Circulation, 2018 ,138(5):527-536.
[5]January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons[J]. Circulation,2019,140(2):e125-e151.
[6] 中华医学会心血管病学分会, 中华心 血管病杂志编辑委员会. 冠心病合并心房颤动患者抗栓管理中国专家共识[J] . 中华心 血管病杂志, 2020, 48 (7): 552-564.
[7]Lopes RD, Hong H, Harskamp RE, et al. Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials[J]. JAMA Cardiol, 2019,4(8): 747-755.
转载:请标明“中国循环杂志”
很多疑难复杂病例,一个医生 一生 也只能见到 一次
“阜外说心脏”入选 国家卫生健康委品牌活动推荐名单
“阜外说心脏” , 采用网络直播的方式 , 向广大心血管疾病患者提供科学、规范、靠谱的心血管疾病自我管理知识 。经国家心血管病中心推荐 , 卫健委宣传司评选 , “阜外说心脏” 系列节目入选国家卫生健康委品牌活动推荐名单 。
每天一个微视频 , 助您心血管健康 。
关于非法网站冒用我刊名义进行征稿的特别提醒
近期我们发现一些网站冒用“中国循环杂志”名义征稿 , 并承诺“职称论文权威快速发表” 。
我刊郑重提醒各位作者 , 向《中国循环杂志》投稿 , 一定要登录中国循环杂志官方网站:
https://www.chinacirculation.org
进入“作者投稿” , 在“作者投稿管理平台”中投稿 。
本刊联系电话:010-68331974
https://chinacirculation.org/WX/home/zxdy
来源:中国循环杂志
推荐阅读
- 南阳医专一附院一例直肠癌合并慢性心衰患者手术后顺利出院
- 再书生命奇迹 陕西榆林二院成功抢救一名狼疮危象合并颅内静脉窦血栓患者
- 长治二院心内科完成首例ICE指导下房颤左心耳封堵一站式手术
- 药物涂层球囊和支架,选哪个更好?
- 长治二院为多种妊娠合并症患者搭起“生命之桥”
- 风湿漫谈 | 从五脏论治类风湿合并间质性肺炎
- 日照心脏病医院:血管内超声指导,零造影剂植入冠脉支架
- 痛风合并糖尿病患者食谱-TAIZAKU赤晶对策解晶代谢科技
- 赛诺菲房颤治疗创新药迈达龙在华获批
- 好消息!待遇就高享受!我市部分门慢、门特病种合并